buprenorphine/samidorphan (ALKS 5461) - Alkermes
Alkermes: Q4 2015 Results Earnings Call (Alkermes) - Mar 10, 2016 - Anticipated presentation of data from P3 FORWARD-4 trial (NCT02158533) in major depressive disorder at ASCP (May 30-Jun 3, 2016) 
Anticipated P3 data • Depression
http://seekingalpha.com/article/3930316-alkermes-plc-alks-richard-f-pops-q4-2015-results-earnings-call-transcript
 
Mar 10, 2016
 
.